​

Abeona Therapeutics Ownership | Who Owns Abeona Therapeutics?

OverviewForecastFinancialsChartTranscripts

Abeona Therapeutics Ownership Summary

Abeona Therapeutics is owned by 5.18% insiders, and 94.81% retail investors. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.62% of its assets in Abeona Therapeutics shares.

ABEO Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAbeona Therapeutics-5.18%94.81%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20241-2,350---1---
Sep 30, 20222-94.44%153,702-99.26%21.16%--100.00%2-60.00%
Jun 30, 202236-26.53%20,889,690-35.97%142.84%11-31.25%5-66.67%
Mar 31, 2022494.26%32,623,572-20.40%221.30%16-27.27%1525.00%
Dec 31, 202147-16.07%40,985,64961.98%416.24%2222.22%12-36.84%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.28M2.62%22.52K
Vanguard US Total Market Shares ETF1.23M2.53%-
Vanguard Institutional Extnd Mkt Idx Tr678.10K1.39%-
Kennedy Micro Cap491.43K1.01%491.43K
Simplify Propel Opportunities ETF408.58K0.84%-
Fidelity Extended Market Index225.24K0.46%-1.44K
abrdn Life Sciences Investors224.36K0.46%-
BlackRock Extended Equity Market K96.05K0.22%-41.00
Extended Equity Market Fund K95.04K0.19%291.00
Kennedy Micro Cap Opportunities87.81K0.18%87.81K

Recent Insider Transactions

DateNameRoleActivityValue
Mar 31, 2025Seshadri Vishwas Chief Executive OfficerSell$119.50K
Jan 29, 2025Alvino Mark-Sell$21.52K
Jan 21, 2025Alvino Mark-Sell$20.40K
Jun 18, 2024Alvino Mark-Sell$116.76K
Jun 18, 2024Silverstein Christine Berni-Sell$116.45K

Insider Transactions Trends

DateBuySell
2025 Q1-3
2024 Q4--
2024 Q3--
2024 Q262
2024 Q111

ABEO Ownership FAQ

Who Owns Abeona Therapeutics?

Abeona Therapeutics shareholders are primarily institutional investors at 0.00%, followed by 5.18% insiders and 94.82% retail investors. The average institutional ownership in Abeona Therapeutics's industry, Biotech Stocks , is 68.48%, which Abeona Therapeutics falls below.

Does Blackrock own Abeona Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Abeona Therapeutics.

Who is the top mutual fund holder of Abeona Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Abeona Therapeutics shares, with 2.62% of its total shares outstanding invested in 1.28M Abeona Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools